Skip to main content
. 2015 Sep 22;6(31):31272–31283. doi: 10.18632/oncotarget.5211

Table 1. Patient and tumor characteristics.

Patient age (n = 18) Median 73,5 (range 54–84)
Tumor type (n = 18) Adenocarcinoma 14 (78%)
Patients n = 16 Positive 7 (43,75%)
Negative 9 (56,25%)
pT (n = 18) 1 1 (5,6%)
2 4 (22,2%)
3 10 (55,5)
4 3 (16,6)
pN (n = 18) 0 9 (50%)
1 4 (22,2%)
1a 1 (5,6%)
2 3 (16,6%)
2b 1 (5,6%)
M (n = 18) 0 13 (72%)
1 5 (28%)
Kras Mutated (n = 18) Positive 8 (44,4%)
Negative 10 (55,6%)